NLM Logo

Ontruzant MeSH Supplementary Concept Data 2025


MeSH Supplementary
Ontruzant
Unique ID
C000631275
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000631275
Entry Term(s)
SB3 antibody
Registry Numbers
0
Heading Mapped to
*Biosimilar Pharmaceuticals
*Trastuzumab
Frequency
3
Note
the first trastuzumab biosimilar approved for routine use in Europe
Source
Future Oncol. 2018 Nov;14(27):2795-2803.
Date of Entry
2019/05/21
Revision Date
2019/05/21
Ontruzant Preferred
SB3 antibody Narrower
page delivered in 0.004s